PD-L1 Positron Emission Tomography Imaging in Patients With Non-Small Cell Lung Cancer: Preliminary Results of the ImmunoPET Phase 0 Study-Reference-Cited by-同舟云学术

PD-L1 Positron Emission Tomography Imaging in Patients With Non-Small Cell Lung Cancer: Preliminary Results of the ImmunoPET Phase 0 Study

Published:2023-11 Issue:3 Volume:117 Page:675-682
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Hegi-Johnson Fiona^ORCID,Rudd Stacey E.,Wichmann Christian W.,Akhurst Tim,Roselt Peter,Sursock Sandra,Trinh Jenny,John Thomas,Devereux Lisa,Donnelly Paul S.,Hicks Rodney J.,Scott Andrew M.,Steinfort Daniel,Fox Stephen,Blyth Benjamin,Parakh Sagun,Hanna Gerard G.,Callahan Jason,Burbury Kate,MacManus Michael

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation

Reference18 articles.

1. Overall survival with durvalumab after chemoradiotherapy in stage III NSCLC;Antonia;New Engl J Med,2018

2. Alteration in tumoural PD-L1 expression and stromal CD8-positive tumour-infiltrating lymphocytes after concurrent chemo-radiotherapy for non-small cell lung cancer;Yoneda;Br J Cancer,2019

3. BRD4-IRF1 axis regulates chemoradiotherapy-induced PD-L1 expression and immune evasion in non-small cell lung cancer;Wang;Clin Transl Med,2022

4. A desferrioxamine B squaramide ester for the incorporation of zirconium-89 into antibodies;Rudd;Chem Commun,2016

5. Automated radiosynthesis of [89Zr] Zr-DFOSq-durvalumab on the iPHASE MultiSyn module;Wichmann;Soc Nuclear Med,2021

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Navigating the landscape of PD-1/PD-L1 imaging tracers: from challenges to opportunities;Frontiers in Medicine;2024-06-07

2. Bifunctional octadentate pseudopeptides as Zirconium-89 chelators for immuno-PET applications;EJNMMI Radiopharmacy and Chemistry;2024-05-06

3. Diagnostic Positron Emission Tomography Imaging with Zirconium-89 Desferrioxamine B Squaramide: From Bench to Bedside;Accounts of Chemical Research;2024-04-26

4. Enhancing anti-CD274 (PD-L1) targeting through combinatorial immunotherapy with bispecific antibodies and fusion proteins: from preclinical to phase II clinical trials;Expert Opinion on Investigational Drugs;2024-02-23

5. Multi-institutional prognostic modeling of survival outcomes in NSCLC patients treated with first-line immunotherapy using radiomics;Journal of Translational Medicine;2024-01-10